Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INCIVEK
- Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
- Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1
- Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection
- Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
- Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers
- Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects
- Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
- Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
- VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C
- A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects
- Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype
- Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501
Clinical trials list
click for details